Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease

被引:49
|
作者
Phillips, Jeffrey S. [1 ]
Das, Sandhitsu R. [2 ]
McMillan, Corey T. [1 ]
Irwin, David J. [1 ]
Roll, Emily E. [1 ]
Da Re, Fulvio [1 ,3 ,4 ]
Nasrallah, Ilya M. [5 ]
Wolk, David A. [6 ]
Grossman, Murray [1 ]
机构
[1] Univ Penn, Penn Frontotemporal Degenerat Ctr, Dept Neurol, 3400 Spruce St,2 Gibson, Philadelphia, PA 19104 USA
[2] Univ Penn, Penn Image Comp & Sci Lab, Philadelphia, PA 19104 USA
[3] Univ Milano Bicocca, Neurosci, Milan, Italy
[4] Univ Milano Bicocca, Milan Ctr Neurosci NeuroMI, Sch Med & Surg, Milan, Italy
[5] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Neurol, Penn Memory Ctr, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Alzheimer disease; cognition; dementia; language; memory; neurofibrillary tangles; primary progressive aphasia; positron emission tomography; posterior cortical atrophy; Tau; POSTERIOR CORTICAL ATROPHY; PARTIAL VOLUME CORRECTION; PRIMARY PROGRESSIVE APHASIA; EMISSION-TOMOGRAPHY TRACER; NEUROFIBRILLARY TANGLES; LOGOPENIC VARIANT; BETA ACCUMULATION; PATHOLOGY; LANGUAGE; ASSOCIATION;
D O I
10.1002/hbm.23874
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Accumulation of paired helical filament tau contributes to neurodegeneration in Alzheimer's disease (AD). F-18-flortaucipir is a positron emission tomography (PET) radioligand sensitive to tau in AD, but its clinical utility will depend in part on its ability to predict cognitive symptoms in diverse dementia phenotypes associated with selective, regional uptake. We examined associations between 18F-flortaucipir and cognition in 14 mildly-impaired patients (12 with cerebrospinal fluid analytes consistent with AD pathology) who had amnestic (n = 5) and non-amnestic AD syndromes, including posterior cortical atrophy (PCA, n = 5) and logopenic-variant primary progressive aphasia (lvPPA, n = 4). Amnestic AD patients had deficits in memory; lvPPA in language; and both amnestic AD and PCA patients in visuospatial function. Associations with cognition were tested using sparse regression and compared to associations in anatomical regions-of-interest (ROIs). F-18-flortaucipir uptake was expected to show regionally-specific correlations with each domain. In multivariate analyses, uptake was elevated in neocortical areas specifically associated with amnestic and non-amnestic syndromes. Uptake in left anterior superior temporal gyrus accounted for 67% of the variance in language performance. Uptake in right lingual gyrus predicted 85% of the variance in visuospatial performance. Memory was predicted by uptake in right fusiform gyrus and cuneus as well as a cluster comprising right anterior hippocampus and amygdala; this eigenvector explained 57% of the variance in patients' scores. These results provide converging evidence for associations between F-18-flortaucipir uptake, tau pathology, and patients' cognitive symptoms.
引用
收藏
页码:691 / 708
页数:18
相关论文
共 50 条
  • [41] Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET
    Devous, Michael D., Sr.
    Fleisher, Adam S.
    Pontecorvo, Michael J.
    Lu, Ming
    Siderowf, Andrew
    Navitsky, Michael
    Kennedy, Ian
    Southekal, Sudeepti
    Harris, Thomas S.
    Mintun, Mark A.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 80 (03) : 1091 - 1104
  • [42] In vitro characterization of tau PET tracers in Alzheimer's Disease
    Ukponu, E.
    Nordberg, A.
    Lemoine, L.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 3) : 27 - 27
  • [43] Neuroimaging of Alzheimer's disease: focus on amyloid and tau PET
    Matsuda, Hiroshi
    Shigemoto, Yoko
    Sato, Noriko
    JAPANESE JOURNAL OF RADIOLOGY, 2019, 37 (11) : 735 - 749
  • [44] Neuroimaging of Alzheimer’s disease: focus on amyloid and tau PET
    Hiroshi Matsuda
    Yoko Shigemoto
    Noriko Sato
    Japanese Journal of Radiology, 2019, 37 : 735 - 749
  • [45] Tau and the fractionated default mode network in atypical Alzheimer's disease
    Putcha, Deepti
    Eckbo, Ryan
    Katsumi, Yuta
    Dickerson, Bradford C.
    Touroutoglou, Alexandra
    Collins, Jessica A.
    BRAIN COMMUNICATIONS, 2022, 4 (02)
  • [46] SPECT and PET imaging in Alzheimer’s disease
    Varvara Valotassiou
    Julia Malamitsi
    John Papatriantafyllou
    Efthimios Dardiotis
    Ioannis Tsougos
    Dimitrios Psimadas
    Sotiria Alexiou
    George Hadjigeorgiou
    Panagiotis Georgoulias
    Annals of Nuclear Medicine, 2018, 32 : 583 - 593
  • [47] Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease
    Aguillon, David
    Langella, Stephanie
    Chen, Yinghua
    Sanchez, Justin S.
    Su, Yi
    Vila-Castelar, Clara
    Vasquez, Daniel
    Zetterberg, Henrik
    Hansson, Oskar
    Dage, Jeffrey L.
    Janelidze, Shorena
    Chen, Kewei
    Fox-Fuller, Joshua T.
    Aduen, Paula
    Martinez, Jairo E.
    Garcia, Gloria
    Baena, Ana
    Guzman, Claudia
    Johnson, Keith A.
    Sperling, Reisa A.
    Blennow, Kaj
    Reiman, Eric M.
    Lopera, Francisco
    Quiroz, Yakeel T.
    ALZHEIMERS & DEMENTIA, 2022, : 2585 - 2594
  • [48] A future for PET imaging in Alzheimer’s disease
    Aurélie Kas
    Raffaella Migliaccio
    Bertrand Tavitian
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 231 - 234
  • [49] PET imaging of amyloid in Alzheimer's disease
    Nordberg, A
    LANCET NEUROLOGY, 2004, 3 (09): : 519 - 527
  • [50] PET Imaging of Neuroinflammation in Alzheimer's Disease
    Zhou, Rong
    Ji, Bin
    Kong, Yanyan
    Qin, Limei
    Ren, Wuwei
    Guan, Yihui
    Ni, Ruiqing
    FRONTIERS IN IMMUNOLOGY, 2021, 12